Literature DB >> 11689639

Genome replication and postencapsidation functions mapping to the nonstructural gene restrict the host range of a murine parvovirus in human cells.

M P Rubio1, S Guerra, J M Almendral.   

Abstract

The infection outcome of the Parvoviridae largely relies on poorly characterized intracellular factors modulated by proliferation, differentiation, and transformation of host cells. We have studied the interactions displayed by the highly homologous p and i strains of the murine parvovirus minute virus of mice (MVM), with a series of transformed cells of rat (C6) and human (U373, U87, SW1088, SK-N-SH) nervous system origin, seeking for molecular mechanisms governing parvovirus host range. The MVMp infection of C6 and U373 cells was cytotoxic and productive, whereas the other nervous cells behaved essentially as resistant to this virus. In contrast, MVMi did not complete its life cycle in any of the human nervous cells, though it efficiently killed the astrocytic tumor cells by two types of nonproductive infections: (i) normal synthesis of all viral macromolecules with a late defect in infectious virion maturation and release to the medium in U373; and (ii) high levels of accumulation of the full set of viral messenger RNAs and of both nonstructural (NS-1) and structural (VP-1 and VP-2) proteins, under a very low viral DNA amplification, in U87 and SW1088 cells. Further analyses showed that U87 was permissive for nuclear transport of MVMi proteins, leading to efficient assembly of empty viral capsids with a normal phosphorylation and VP1-to-VP2 ratio. The DNA amplification blockade in U87 occurred after conversion of the incoming MVMi genome to the monomeric replicative form, and it operated independently of the delivery pathway used by the viral particle, since it could not be overcome by transfection with cloned infectious viral DNA. Significantly, a chimeric MVMi virus harboring the coding region of the nonstructural (NS) gene replaced with that of MVMp showed a similar pattern of restriction in U87 cells as the parental MVMi virus, and it attained in U373 cultures an infectious titer above 100-fold higher under equal levels of DNA amplification and genome encapsidation. The results suggest that the activity of complexes formed by the NS polypeptides and recruited cellular factors restrict parvovirus DNA amplification in a cell type-dependent manner and that NS functions may in addition determine MVM host range acting at postencapsidation steps of viral maturation. These data are relevant for understanding the increased multiplication of autonomous parvovirus in some transformed cells and the transduction efficacy of nonreplicative parvoviral vectors, as well as a general remark on the mechanisms by which NS genes may regulate viral tropism and pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689639      PMCID: PMC114744          DOI: 10.1128/JVI.75.23.11573-11582.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  86 in total

1.  Parvovirus initiation factor PIF: a novel human DNA-binding factor which coordinately recognizes two ACGT motifs.

Authors:  J Christensen; S F Cotmore; P Tattersall
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Minute virus of mice initiator protein NS1 and a host KDWK family transcription factor must form a precise ternary complex with origin DNA for nicking to occur.

Authors:  J Christensen; S F Cotmore; P Tattersall
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  The two transcription units of the autonomous parvovirus minute virus of mice are transcribed in a temporal order.

Authors:  K E Clemens; D J Pintel
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

4.  The distribution and kinetics of polyomavirus in lungs of intranasally infected newborn mice.

Authors:  K Gottlieb; L P Villarreal
Journal:  Virology       Date:  2000-01-05       Impact factor: 3.616

5.  Sensitization of transformed rat cells to parvovirus MVMp is restricted to specific oncogenes.

Authors:  N Salomé; B van Hille; N Duponchel; G Meneguzzi; F Cuzin; J Rommelaere; J J Cornelis
Journal:  Oncogene       Date:  1990-01       Impact factor: 9.867

6.  Replication of Aleutian mink disease parvovirus in vivo is influenced by residues in the VP2 protein.

Authors:  J M Fox; M A McCrackin Stevenson; M E Bloom
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro.

Authors:  A Srivastava; E Bruno; R Briddell; R Cooper; C Srivastava; K van Besien; R Hoffman
Journal:  Blood       Date:  1990-11-15       Impact factor: 22.113

8.  Restriction of porcine parvovirus replication in nonpermissive cells.

Authors:  K Oraveerakul; C S Choi; T W Molitor
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

9.  Reciprocal productive and restrictive virus-cell interactions of immunosuppressive and prototype strains of minute virus of mice.

Authors:  P Tattersall; J Bratton
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

10.  Functional implications of the structure of the murine parvovirus, minute virus of mice.

Authors:  M Agbandje-McKenna; A L Llamas-Saiz; F Wang; P Tattersall; M G Rossmann
Journal:  Structure       Date:  1998-11-15       Impact factor: 5.006

View more
  16 in total

Review 1.  Oncolytic virus therapy for glioblastoma multiforme: concepts and candidates.

Authors:  Guido Wollmann; Koray Ozduman; Anthony N van den Pol
Journal:  Cancer J       Date:  2012 Jan-Feb       Impact factor: 3.360

2.  Translation control by protein kinase R restricts minute virus of mice infection: role in parvovirus oncolysis.

Authors:  Iván Ventoso; Juan J Berlanga; José M Almendral
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

3.  Distinct host cell fates for human malignant melanoma targeted by oncolytic rodent parvoviruses.

Authors:  Ellen M Vollmers; Peter Tattersall
Journal:  Virology       Date:  2013-08-09       Impact factor: 3.616

4.  LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells.

Authors:  Justin C Paglino; Koray Ozduman; Anthony N van den Pol
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

5.  Replication of minute virus of mice DNA is critically dependent on accumulated levels of NS2.

Authors:  Eun-Young Choi; Ann E Newman; Lisa Burger; David Pintel
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

6.  Virulent variants emerging in mice infected with the apathogenic prototype strain of the parvovirus minute virus of mice exhibit a capsid with low avidity for a primary receptor.

Authors:  Mari-Paz Rubio; Alberto López-Bueno; José M Almendral
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Viral oncolysis that targets Raf-1 signaling control of nuclear transport.

Authors:  Laura Riolobos; Noelia Valle; Eva Hernando; Beatriz Maroto; Michael Kann; José M Almendral
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

8.  Parvovirus infection suppresses long-term repopulating hematopoietic stem cells.

Authors:  José C Segovia; Guillermo Guenechea; Jesús M Gallego; José M Almendral; Juan A Bueren
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Replicating parvoviruses that target colon cancer cells.

Authors:  M Malerba; L Daeffler; J Rommelaere; R D Iggo
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Host cell specificity of minute virus of mice in the developing mouse embryo.

Authors:  Refael Itah; Jacov Tal; Claytus Davis
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.